The next goal is qualification for SCI and SCIE. This will take time. For this, the following two strategies are essential, many high quality articles must be published in Clin Exp Vaccine Res and the impact factor of Clin Exp Vaccine Res must be high. This will take at least more than 2-3 years. Therefore, for the following 2-3 years, we ask for your support for submission of many high quality articles (especially by authors from other countries) and citation of articles in Clin Exp Vaccine Res in other articles published in SCI(E) journals.
A high standard journal is a reflection of the quality and standards of an acade mic society. The registry of Clin Exp Vaccine Res into PubMed Central and PubMed is an important opportunity for expanding acknowledgement of Clin Exp Vaccine Res and The Korean Vaccine Society.
We kindly ask for your warm hearted interest in the growth and development of Clin Exp Vaccine Res. The members of Clin Exp Vaccine Res will endeavor to make up to your expectations.
We thank those who worked so hard and supported us through the many processes in publication and establishment of the web-site, especially Jung Soo Kim, 
